The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loss, G. E.
Right arrow Articles by Sant, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loss, G. E., Jr
Right arrow Articles by Sant, A. J.

The Journal of Immunology, Vol 150, Issue 8 3187-3197, Copyright © 1993 by American Association of Immunologists


ARTICLES

Invariant chain retains MHC class II molecules in the endocytic pathway

GE Loss Jr and AJ Sant
Department of Surgery, University of Chicago, IL 60637.

During exocytosis of MHC class II, the class II alpha beta heterodimer associates with a third polypeptide termed invariant chain (Ii). Class II and Ii are coordinately processed and transported until proteolytic cleavage of Ii in an acidic compartment immediately before class II surface expression. Although the lysosomotropic agent chloroquine (CQ) prevents dissociation of class II/Ii within the cell, the ultimate fate of these complexes has not been determined. We considered two alternative possibilities. If Ii encodes an intracellular retention signal, then persistent association of Ii with class II could lead to intracellular accumulation of class II/Ii complexes. Alternatively, if Ii does not block further transport of class II, then CQ treatment should result in aberrant expression of class II/Ii complexes at the cell surface. Ltk- and EL4 cells transfected with I-A(d) alone or I- A(d) plus Ii were treated with CQ and examined for changes in surface class II and Ii expression. Anti-Ii mAb surface staining did not increase with prolonged CQ treatment, but a dramatic decrease in surface class II staining was observed. This decrease in class II was observed both with genomic Ii and p31 cDNA transfectants and was rapidly reversed upon drug removal. Accumulation of Ii and class II within treated cells was directly observed by intracellular staining. Similar effects on MHC surface expression were observed with the lysosomotropic agents primaquine and NH4Cl and the cysteine protease inhibitor leupeptin. Ii-negative cells treated in parallel displayed no effect of the lysosomotropic agents or leupeptin on class II surface staining. These results indicate that dissociation of Ii from newly synthesized class II is required for transport of the alpha beta dimer to the cell surface, and suggest that Ii serves to retain class II molecules in a post-Golgi endocytic compartment.


This article has been cited by other articles:


Home page
J EndocrinolHome page
M. Szaszak, H.-D. Chen, H.-C. Chen, A. Baukal, L. Hunyady, and K. J Catt
Identification of the invariant chain (CD74) as an angiotensin AGTR1-interacting protein
J. Endocrinol., November 1, 2008; 199(2): 165 - 176.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. L. Podolin, B. J. Bolognese, D. C. Carpenter, T. G. Davis, R. A. Johanson, J. H. Fox, E. Long III, X. Dong, R. W. Marquis, S. M. LoCastro, et al.
Inhibition of Invariant Chain Processing, Antigen-Induced Proliferative Responses, and the Development of Collagen-Induced Arthritis and Experimental Autoimmune Encephalomyelitis by a Small Molecule Cysteine Protease Inhibitor
J. Immunol., June 15, 2008; 180(12): 7989 - 8003.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Huang, S. Gilfillan, S. Kim, B. Thompson, X. Wang, A. J. Sant, D. H. Fremont, O. Lantz, and T. H. Hansen
MR1 uses an endocytic pathway to activate mucosal-associated invariant T cells
J. Exp. Med., May 12, 2008; 205(5): 1201 - 1211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-B. Wang, I. Ghiran, K. Matthaei, and P. F. Weller
Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells
J. Immunol., December 1, 2007; 179(11): 7585 - 7592.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Soualhine, A.-E. Deghmane, J. Sun, K. Mak, A. Talal, Y. Av-Gay, and Z. Hmama
Mycobacterium bovis Bacillus Calmette-Guerin Secreting Active Cathepsin S Stimulates Expression of Mature MHC Class II Molecules and Antigen Presentation in Human Macrophages
J. Immunol., October 15, 2007; 179(8): 5137 - 5145.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Sendide, A.-E. Deghmane, D. Pechkovsky, Y. Av-Gay, A. Talal, and Z. Hmama
Mycobacterium bovis BCG Attenuates Surface Expression of Mature Class II Molecules through IL-10-Dependent Inhibition of Cathepsin S
J. Immunol., October 15, 2005; 175(8): 5324 - 5332.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. J. Poloso, A. Muntasell, and P. A. Roche
MHC Class II Molecules Traffic into Lipid Rafts during Intracellular Transport
J. Immunol., October 1, 2004; 173(7): 4539 - 4546.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
K. Sendide, A.-E. Deghmane, J.-M. Reyrat, A. Talal, and Z. Hmama
Mycobacterium bovis BCG Urease Attenuates Major Histocompatibility Complex Class II Trafficking to the Macrophage Cell Surface
Infect. Immun., July 1, 2004; 72(7): 4200 - 4209.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Lautwein, M. Kraus, M. Reich, T. Burster, J. Brandenburg, H. S. Overkleeft, G. Schwarz, W. Kammer, E. Weber, H. Kalbacher, et al.
Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner
J. Leukoc. Biol., May 1, 2004; 75(5): 844 - 855.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Rajagopalan, M. K. Smart, C. J. Krco, and C. S. David
Expression and Function of Transgenic HLA-DQ Molecules and Lymphocyte Development in Mice Lacking Invariant Chain
J. Immunol., August 15, 2002; 169(4): 1774 - 1783.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
T. W. Nordeng, T. F. Gregers, T. L. Kongsvik, S. Meresse, J.-P. Gorvel, F. Jourdan, A. Motta, and O. Bakke
The Cytoplasmic Tail of Invariant Chain Regulates Endosome Fusion and Morphology
Mol. Biol. Cell, June 1, 2002; 13(6): 1846 - 1856.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. P. Thayer, L. Ignatowicz, D. A. Weber, and P. E. Jensen
Class II-Associated Invariant Chain Peptide-Independent Binding of Invariant Chain to Class II MHC molecules
J. Immunol., February 1, 1999; 162(3): 1502 - 1509.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Thery, V. Brachet, A. Regnault, M. Rescigno, P. Ricciardi-Castagnoli, C. Bonnerot, and S. Amigorena
MHC Class II Transport from Lysosomal Compartments to the Cell Surface Is Determined by Stable Peptide Binding, But Not by the Cytosolic Domains of the {alpha}- and {beta}-Chains
J. Immunol., September 1, 1998; 161(5): 2106 - 2113.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-P. Gorvel, J.-M. Escola, E. Stang, and O. Bakke
Invariant Chain Induces a Delayed Transport from Early to Late Endosomes
J. Biol. Chem., February 10, 1995; 270(6): 2741 - 2746.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S De Souza Leao, T Lang, E Prina, R Hellio, and J. Antoine
Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells
J. Cell Sci., January 10, 1995; 108(10): 3219 - 3231.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Brunet, A. Samaan, F. Deshaies, T. J. Kindt, and J. Thibodeau
Functional Characterization of a Lysosomal Sorting Motif in the Cytoplasmic Tail of HLA-DObeta
J. Biol. Chem., November 17, 2000; 275(47): 37062 - 37071.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.